| Product NDC: | 52389-172 |
| Proprietary Name: | Nauzene |
| Non Proprietary Name: | Sodium Citrate |
| Active Ingredient(s): | 4.35; 4.17; .921 g/15mL; g/15mL; g/15mL & nbsp; Sodium Citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52389-172 |
| Labeler Name: | Alva-Amco Pharmacal Companies, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part357 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20000215 |
| Package NDC: | 52389-172-04 |
| Package Description: | 118 mL in 1 BOTTLE, PLASTIC (52389-172-04) |
| NDC Code | 52389-172-04 |
| Proprietary Name | Nauzene |
| Package Description | 118 mL in 1 BOTTLE, PLASTIC (52389-172-04) |
| Product NDC | 52389-172 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Sodium Citrate |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20000215 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Alva-Amco Pharmacal Companies, Inc. |
| Substance Name | DEXTROSE; FRUCTOSE; TRISODIUM CITRATE DIHYDRATE |
| Strength Number | 4.35; 4.17; .921 |
| Strength Unit | g/15mL; g/15mL; g/15mL |
| Pharmaceutical Classes |